Bank of America, Truist Financial, and Royal Bank of Canada lowered price targets for Alnylam Pharmaceuticals on July 14, 2026.
8 reports, 3 independent
Updated Fri 00:00
Mostly repetition
- Reports
- 8
- Developments
- 1
- Repetition
- 88%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America, Truist Financial, and Royal Bank of Canada lowered price targets for Alnylam Pharmaceuticals on July 14, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alnylam Pharmaceuticals
biopharmaceutical company
-
Bank of America
American multinational banking and financial services corporation
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Royal Bank of Canada
financial institution in Canada
Related events
- Financial institutions including Truist Financial, Royal Bank of Canada, Bank of America, and TD Securities raised price targets on October 23, 2026.
- Bank of America, Deutsche Bank, and Truist Financial reduced their price targets for Costco on November 11, 2026.
- Royal Bank of Canada and Truist Financial lowered price targets for Ardent Health, Inc. on July 14, 2026.
- Royal Bank of Canada reduced its price objective while Desjardins increased its price target on shares.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.